Webinars and Podcasts

Webinars

Sepsis Webinar Series: Latest insights on bacterial contamination in platelet concentrates.

Are you aware of the continuing risk of septic transfusion reactions?
We will bring you up to date with the latest, most relevant insights in a series of short educational webinars hosted by experts to cover three key subjects:

Part 1: Bacterial contamination rates in platelet components

Introduction
Marcus Picard-Maureau | Scientific Affairs Director EMEA | Cerus Europe 

Bacterial contamination rate of platelet components by primary culture and residual risk associated with false negatives: results from two recent meta-analyses 
Ryan A. Metcalf | Medical Director, Blood Bank Assistant Professor; Inpatient Chief Value Officer; Department of Pathology | University of Utah and ARUP Laboratories

Transfusion transmitted bacterial infections in patients: why are they often undetected and underreported?
Richard Benjamin | Chief Medical Officer | Cerus Global Headquarters

Part 2: Rationale on why bacterial contaminations don’t always cause clinical sepsis

Introduction
Marion Lanteri | Global Scientific Affairs Director | Cerus Global Headquarters

Merits and pitfalls of automated bacterial culture methods in improving bacterial safety of platelet concentrates 
Sandra Ramirez-Arcos | Senior Scientist, Canadian Blood Services and Adjunct Professor, University of Ottawa | Ottawa, Canada

Reduction in the risk of bacterial contamination, platelet components prepared with Amotosalen-UVA photochemical treatment. What can we conclude after 15 years of routine experience?
Laurence Corash | Chief Scientific Officer |  Cerus Global Headquarters

Part 3: Why septic transfusion reactions often remain invisible and underreported 

Podcasts

Preparing Our Blood Supply for the Next Pandemic with Dr. Susan Stramer

August 2020
Dr. Stramer discusses how pathogen outbreaks can impact blood safety and availability, and what to do about it.
How can blood suppliers prepare for the next pandemic? While SARS-Cov-2 does not appear to be transfusion-transmitted, the rapid progression of the new coronavirus has shown why it’s critical for blood suppliers to think ahead – and take a proactive approach to blood safety.